Pediatric Infection: Management of Fever and Transmission

Comprehensive review flashcards covering pediatric infectious diseases, communicable transmission routes, fever thermoregulation, and nursing management.

Incubation period

The timeframe between initial exposure to an infectious pathogen and the clinical development of symptoms.

Prodrome

An early phase of clinical manifestations that occurs before the overt characteristic clinical syndrome of a disease appears.

Common infectious symptom cluster

A typical grouping of manifestations comprising fever, mucous membrane/skin rashes and lesions, poor appetite, muscle aches, malaise, nausea, vomiting, and diarrhea.

Fever (rectal / tympanic route threshold)

An elevation in body temperature reaching $38.0^\circ\text{C}$ ($100.4^\circ\text{F}$) or higher when measured via the rectal or tympanic route.

Fever (oral / temporal route threshold)

An elevation in body temperature reaching $37.8^\circ\text{C}$ ($100.0^\circ\text{F}$) or higher when measured via the oral or temporal route.

Hypothalamus (thermoregulation role)

The brain structure that acts as the body's thermostat to control and modulate temperature regulation.

Fever benefits: microbial inhibition and trace minerals

Slows the growth and reproduction of organisms that thrive at lower temperatures and decreases serum levels of zinc, iron, and copper, which are necessary for bacterial reproduction.

Fever benefits: immune response mobilization

Enhances the physiological immune response by increasing neutrophil production and enhancing phagocytosis.

Inherently harmful fever threshold

The critically high core body temperature level of $41.0^\circ\text{C}$ ($105.9^\circ\text{F}$), at which fever begins to become inherently harmful.

Antipyretics (mechanism of action)

Pharmaceutical agents that work by inhibiting prostaglandin synthesis, thereby lowering the hypothalamic temperature set points and reducing fever.

Pediatric acetaminophen dosage

The recommended safe antipyretic dosing parameter of $10\text{--}15\,\text{mg/kg/dose}$.

Pediatric ibuprofen dosage

The recommended safe antipyretic dosing parameter of $4\text{--}10\,\text{mg/kg/dose}$.

Aspirin pediatric contraindication

Aspirin is no longer recommended for children due to its direct association with Reye syndrome.

Sponge bath fever management guideline

Sponging is not recommended because lukewarm water can increase shivering and discomfort; alcohol should never be used for sponge baths.

Varicella zoster transmission modes

Transmission occurring via airborne routes and direct contact with fluid from skin lesions.

Chickenpox incubation period

The time between exposure and symptom development, typically spanning $14\text{--}21\,\text{days}$.

Chickenpox communicability window

Most contagious $1\text{--}2\,\text{days}$ ($12\text{--}24\,\text{hours}$) before the rash appears to shortly after rash onset, remaining contagious until all skin lesions have crusted over.

Chickenpox vesicular rash progression

A cutaneous eruption that begins as macules (flat red spots), progresses to papules (raised bumps), then becomes clear fluid-filled vesicles before crusting into brown scabs.

Chickenpox rash distribution pattern

Exanthem that characteristically starts on the trunk, scalp, and face and then spreads outward to the rest of the body (limbs).

Varicella oral enanthem

Ulcerative lesions appearing in the mouth and mucous membranes that cause localized pain and lead to decreased oral fluid intake.

Newborn vulnerability window for varicella

Newborns become vulnerable to varicella once protective maternal antibodies disappear at $2\text{--}3\,\text{months}$ of age.

Secondary bacterial complications of chickenpox

Complications arising from skin barrier breakdown, including cellulitis, sepsis, and meningitis.

Varicella zoster immune globulin (VZIG) indications

Immunoglobulin therapy recommended for exposed pregnant women (within $96\,\text{hours}$), exposed newborns (within $48\,\text{hours}$ of birth), or within $10\,\text{days}$ to hospitalized premature neonates and unimmunized immunocompromised children.

Varicella diagnostic testing

Polymerase chain reaction (PCR) or direct antibody testing performed on fluid collected from a vesicle or scab.

Intravenous acyclovir in varicella

Antiviral treatment indicated for immunocompromised children and those receiving high-dose corticosteroids, requiring close monitoring of renal function.

Post-exposure varicella vaccination

Active immunization administered within $72\,\text{hours}$ of exposure to reduce the severity of or prevent infection.

Chickenpox school return clearance

Children must not return to school or daycare until all cutaneous lesions have completely crusted over.

Corynebacterium diphtheriae

The causative bacterial pathogen of diphtheria, transmitted via droplet and contact with nasal/eye discharge, skin lesions, contaminated items, or unpasteurized milk.

Diphtheria incubation period

The timeframe between exposure to the bacterium and the development of clinical symptoms, lasting $2\text{--}7\,\text{days}$.

Diphtheria communicability timeframe

An infected individual remains contagious for $2\text{--}4\,\text{weeks}$ without treatment, or until $4\,\text{days}$ after starting appropriate antibiotic therapy.

Adherent grayish pharyngeal membrane

A hallmark diphtheria pseudomembrane that extends to the trachea causing severe airway obstruction; attempting to remove it causes bleeding.

"Bull's neck" lymphadenitis

Marked cervical lymph node enlargement and soft tissue edema of the neck seen in severe Corynebacterium diphtheriae infection.

Diphtheria endotoxin complications

A bacterial endotoxin that causes myocarditis and peripheral neuropathy (manifesting as diplopia, slurred speech, difficulty swallowing, or palate paralysis).

IV equine antitoxin

A specific neutralizing antitoxin administered intravenously to counteract circulating diphtheria toxin.

Diphtheria antibiotic regimen

Therapy with IV or IM penicillin G administered for $14\,\text{days}$, transitioning to oral erythromycin once the child is able to swallow.

Diphtheria isolation release criteria

Maintenance of standard and droplet precautions until two successive cultures are confirmed negative for Corynebacterium diphtheriae.

Diphtheria bedside emergency management

Keeping emergency airway equipment readily available at the bedside, delivering humidified $O_2$, and using gentle oral suctioning as necessary.

Geographic risk regions for diphtheria

Higher incidence occurring during colder months across Africa, Asia, Latin America, the Middle East, and states of the former Soviet Union.

Bed rest rationale in diphtheria

Strict bed rest maintained to reduce metabolic demands and minimize the risk of acute myocarditis complications.

Hand, foot, and mouth disease pathogens

Viral infections caused by Group A and Group B coxsackieviruses belonging to the enterovirus genus.

Enterovirus transmission routes

Direct spread occurring primarily via fecal-oral and respiratory contact routes.

Hand, foot, and mouth disease incubation period

The timeframe between exposure to the virus and the development of initial symptoms, lasting $3\text{--}6\,\text{days}$.

Prolonged enteroviral shedding

Viral shedding and disease transmission that continue in feces and secretions for weeks or months after the initial infection.

Hand, foot, and mouth disease lesions

Exanthem and enanthem consisting of flat red spots and blisters located on the palms, soles of the feet, and inside the oral cavity.

Oral enanthem consequences in HFMD

Painful swallowing caused by oral mucosal blisters and ulcers that leads directly to poor appetite and potential dehydration.

Seasonality of enterovirus infections

Infections that occur most frequently during the summer and early fall months.

Enterovirus diagnostic confirmation

Polymerase chain reaction (PCR) or viral culture obtained from stool, throat swabs, or primary infection site lesions.

IV immune globulin (IVIG) in enteroviruses

Therapy utilized for life-threatening neonatal enteroviral infections and in pediatric patients with organ transplants or malignancies.

Enterovirus natural clinical duration

A self-limiting illness with no curative antiviral therapy that typically resolves within $7\text{--}10\,\text{days}$.

Dietary nursing interventions for HFMD

Encouraging liquids, cool drinks, and soft bland foods while strictly avoiding citrus, salty, or spicy foods that irritate mouth sores.

Oral hygiene care for HFMD

Offering warm saline mouth rinses while avoiding gargling to soothe oral mucosa and prevent aspiration.

Human parvovirus B19

The causative viral agent of fifth disease (erythema infectiosum), transmitted via contact and respiratory droplets.

Fifth disease incubation range

The interval between viral exposure and the emergence of symptoms, ranging from $4\text{--}21\,\text{days}$.

Fifth disease infectivity window

Most contagious before the onset of the rash; the child is no longer contagious once the rash appears.

Fifth disease prodrome

A mild initial illness lasting $2\text{--}3\,\text{days}$ presenting with low-grade fever, headache, chills, nausea, body aches, malaise, and itching.

"Slapped face" appearance

The characteristic exanthem of fifth disease featuring pinkish/red cheeks accompanied by circumoral paleness around the mouth.

Lacelike exanthem of fifth disease

Macular spots on the trunk and limbs with a distinctive lacelike appearance that characteristically spare the palms and soles.

Fifth disease exanthem recrudescence triggers

The rash fades over $1\text{--}3\,\text{weeks}$ but can transiently reappear if the skin is exposed to sunlight or irritated.

Transient aplastic crisis

A serious complication of parvovirus B19 in children with underlying hemolytic conditions where the body temporarily stops producing red blood cells.

Fetal complications of parvovirus B19

Infection during pregnancy that results in fetal hydrops, profound fetal anemia, or spontaneous abortion.

Parvovirus-associated polyarthropathy

A joint-related complication causing acute or persistent joint pain following human parvovirus B19 infection.

Fifth disease hospital precautions

Implementation of standard and droplet precautions, reserving isolation specifically for patients experiencing aplastic crisis or immunosuppression.

School attendance guideline for fifth disease

Children may safely return to school or childcare once the rash appears, as they are no longer contagious at that stage.

Haemophilus influenzae type b (Hib)

A coccobacillus transmitted via droplets and contact that colonizes the upper respiratory tract and invades the bloodstream.

Hib communicability window

Contagious for approximately $3\,\text{days}$ from the initial onset of symptoms.

Invasive Hib clinical syndromes

Systemic bacterial manifestations including meningitis, epiglottitis, pneumonia, infectious arthritis, cellulitis, and infant sepsis.

Neonatal Hib transmission modes

Infection acquired by neonates through the aspiration of amniotic fluid or direct contact with maternal vaginal secretions during birth.

Hib diagnostic confirmation

Bacterial identification confirmed via cultures obtained from blood, cerebrospinal fluid, or middle ear aspirate.

Hib IV antibiotic duration

A standard course of intravenous antibiotic therapy administered for $10\,\text{days}$.

Dexamethasone adjunct in Hib meningitis

A corticosteroid administered to reduce the incidence and severity of permanent neurologic sequelae resulting from meningitis.

Rifampin chemoprophylaxis in Hib

An oral antibiotic administered to unprotected household contacts to prevent secondary transmission.

Rifampin bodily fluid discoloration

The benign side effect of rifampin turning urine, tears, and other bodily fluids an orange color that can cause permanent staining.

Hib droplet precaution duration

Standard droplet precautions maintained until fully $24\,\text{hours}$ after the initiation of effective systemic antibiotic therapy.

Non-invasive Hib clinical manifestations

Localized upper respiratory infections caused by H. influenzae, including sinusitis, otitis media, bronchitis, and pericarditis.

Unimmunized vulnerability to Hib

Lack of vaccination represents the primary risk factor predisposing children to invasive disease, severe sequelae, and death.

Orthomyxoviruses (influenza types A, B, and C)

The RNA viruses responsible for acute influenza, transmitted through respiratory droplet spread and contact.

Influenza incubation timeframe

A very short incubation period lasting between $1\text{--}4\,\text{days}$ from exposure to clinical onset.

Influenza communicability window

Viral transmission capability spanning from $1\,\text{day}$ before symptom onset up to $5\text{--}7\,\text{days}$ after symptoms begin.

Influenza febrile parameters

Systemic illness featuring acute fever spikes between $38.0\text{--}40.0^\circ\text{C}$ ($100.4\text{--}104.0^\circ\text{F}$) accompanied by chills, malaise, headache, and body aches.

Pediatric influenza gastrointestinal manifestations

Presentations common in children including nausea, vomiting, diarrhea, and abdominal pain alongside standard respiratory symptoms.

Peak influenza seasonal activity

The seasonal window during which influenza viruses are most active, extending from October to March.

Neurological complications of influenza

Central nervous system complications including febrile seizures, Guillain-Barré syndrome (GBS), meningitis, and encephalitis.

Rapid antigen testing for influenza

Diagnostic identification of influenza viruses performed using nasopharyngeal swabs or nasal washings.

Antiviral administration window for influenza

Antiviral medications should be initiated within $48\,\text{hours}$ of symptom onset to be clinically effective.

Pediatric influenza vaccination initiation

Annual influenza immunization begins routinely at $6\,\text{months}$ of age.

Influenza vaccine priming schedule

Children under $9\,\text{years}$ of age receiving the influenza vaccine for the first time require $2\,\text{doses}$ administered $4\,\text{weeks}$ apart.

School clearance after influenza

Children must be kept home from school until fully $24\,\text{hours}$ after fever has completely resolved without antipyretics.

Morbillivirus

The causative paramyxovirus of measles (rubeola), spread through airborne droplets, coughing, sneezing, and contaminated contact.

Measles incubation duration

The typical duration between viral exposure and initial clinical symptoms, lasting $7\text{--}14\,\text{days}$.

Measles communicability window

Contagious from $4\,\text{days}$ before the rash appears until $4\,\text{days}$ after the rash emerges.

The 3 C's of measles

The pathognomonic clinical triad consisting of cough, coryza, and conjunctivitis.

Measles febrile peak

High fevers reaching up to $40.5^\circ\text{C}$ ($105.0^\circ\text{F}$) that typically last for $1\text{--}3\,\text{days}$.

Coryza

Inflammation of the mucous membrane inside the nose, caused especially by a cold or hay fever and presenting as severe rhinorrhea.

Koplik spots

Small, $1\text{--}3\,\text{mm}$ gray or blue-gray punctate lesions appearing on the buccal mucosa $1\text{--}2\,\text{days}$ before the measles rash.

Measles confluent maculopapular exanthem

A dark red or purple blotchy maculopapular rash that joins together (becomes confluent), starting on the face and spreading to the trunk and extremities.

Measles exanthem peak timing

The cutaneous eruption reaches its maximum intensity and distribution within $2\text{--}4\,\text{days}$ after appearing.

Photophobia management in measles

Keeping room lighting dimmed as a supportive nursing intervention to relieve ocular pain and photophobia.

Post-exposure prophylaxis for measles (MMR and IG)

MMR vaccine administered within $72\,\text{hours}$ or immune globulin within $6\,\text{days}$ of exposure to prevent or reduce disease severity.

Measles hospital airborne isolation duration

Standard airborne precautions maintained until the fifth day of the rash if the child is hospitalized.

Severe complications of measles

Otitis media, diarrhea, secondary bacterial infections, severe lethal pneumonia, and permanent brain damage from encephalitis.